The care of patients with Liver, Pancreas and Bile Duct disease requires multiple disciplines. To make sure our patients have the best outcomes, each patient's case is discussed among our team of dedicated physicians at weekly conferences. Our team includes a Liver, Pancreas and Biliary Surgery, Hepatology, Interventional Endoscopy, Interventional Radiology, Gastroenterology, Medical Oncology, Radiation Oncology, and an expert Radiologist in body imaging.
Dr. de la Torre is Director of Liver, Pancreas and Biliary Surgery at St. Joseph's Medical Center. He is also Adjunct Associate Professor of Surgery at Rutgers University, Newark Campus.
Medical Doctorate
Johns Hopkins School of Medicine
Baltimore, Maryland
Class of 1989
Johns Hopkins School of Medicine
Baltimore, Maryland
Class of 1989
Visiting Scholar Training Program
Division of Liver Transplant and Hepatobiliary Surgery
(Live Donor Liver Transplant Training)
Asan Medical Center
Seoul, South Korea
March 9-20, 2015
Liver Transplant Fellowship
New Jersey Medical School
University Hospital, University of Medicine & Dentistry of New Jersey
Newark, New Jersey
1999-2000
Kidney and Pancreas Transplant Fellowship
University of Maryland Medical Systems
Baltimore, Maryland
1995-1998
General Surgery Residency
New Jersey Medical School
University Hospital, University of Medicine & Dentistry of New Jersey
Newark, New Jersey
1990-1995
Division of Liver Transplant and Hepatobiliary Surgery
(Live Donor Liver Transplant Training)
Asan Medical Center
Seoul, South Korea
March 9-20, 2015
Liver Transplant Fellowship
New Jersey Medical School
University Hospital, University of Medicine & Dentistry of New Jersey
Newark, New Jersey
1999-2000
Kidney and Pancreas Transplant Fellowship
University of Maryland Medical Systems
Baltimore, Maryland
1995-1998
General Surgery Residency
New Jersey Medical School
University Hospital, University of Medicine & Dentistry of New Jersey
Newark, New Jersey
1990-1995
American Board of Surgery 1999, Recertified 2009
Fellow of the American College of Surgeons 2012
Fellow of the American College of Surgeons 2012
35. Mashchenko I, Trtchounian A, Buchultz C, de la Torre AN. A Sling Technique For Laparoscopic Resection of Segment Seven of the Liver. Journal of the Society of Laparoendoscopic Surgery 2018 Apr-Jun; 22(2)
34. de la Torre AN, Contractor S, Castaneda I, Cathcart C, Razdan D, Clyde D, Kisza P, Gonzalez S, Salazar. A Phase I trial using local regional treatment, nonlethal irradiation, intratumoral and systemic polyinosinic-polycytidylic acid polylysine carboxymethylcellulose to treat liver cancer: in search of the abscopal effect. J Hepatocell Carcinoma. 2017 Aug 7;4:111-121
33. de la Torre AN, Castaneda I, Elkholy N, Tham N, Peyton A, Samanta A, Leevy CB.. Patient Targeted Informatics to Increase Blood Testing, Diagnosis and Vaccination in High Risk Populations for Chronic Viral Hepatitis. 2017 Jun 21. JVH [Epub ahead of print]
32. Lasfer A, Ziosa A, de la Torre AD, Cohen-Solal, KA IFN-λ: A New Inducer of Local Immunity against Cancer and Infections. Frontiers in Immunology 2016 December 15; 7: 598
31. Lasfar A, de la Torre AN, Abushahba W, Cohen-Solal KA, Castaneda I, Yuan Y, Reuhl K, Raveche E, Laskin DL, Kotenko SV. Combination of IFN-α and IFN-λ induce complete remission in BNL hepatoma model: Relevance of IFN-α/λ cross-talk and host immunomodulation. Oncotarget 2016 Aug 2; 7(31): 49259–49267
30 Botros Y, Mathews M, Patel H, Shah N, Baddoura W, de la Torre A Case Report Recurrent Hepatocellular Carcinoma in Patient with Crohn’s Disease: Incidental or Expected Outcome of Azathioprine? . Recurrent Hepatocellular Carcinoma in Patient with Crohn’s Disease: Incidental or Expected Outcome of Azathioprine?. Case Reports in Gastrointestinal Medicine 2015;2015:939136
29. Ambovex® as a novel immunological modulator drug for treatment of Hepato-Cellular Carcinoma (HCC) in liver: Phase II clinical trial. Salama H, Ahmad H, Elchagea I, Zekri RA, Medhat E, Bahnassy A, Lange M, Rabbat M, de la Torre AN, Punamiya P. Journal of Hepatocellular Carcinoma 2015 2:79-89
28. Muir AJ, Shiffman ML, Zaman A, Yoffe B, de la Torre A, Flamm S, Gordon S, Marotta P, Vierling J, Lopez-Talavera JC, Byrnes-Blake K, Fontana D, Freeman J, Gray T, Hausman D, Hunder NN, Lawitz E. Phase 1b Dose- Ranging Study of PEG-Interferon-Lambda Plus Ribavirin in Patients with Chronic Genotype 1 Hepatitis C Virus Infection. Hepatology. 2010 May 14
27. Abushahba W, Lasfar A , Balan M, Castaneda I, Yuan Y, Prescott L, Reuhl K, Raveche E, de la Torre AN, Kotenko SV. Antitumor Activity of Type I and Type III Interferons in BNL Hepatoma Model. Cancer Immunol Immunother. 2010 Mar 9
26. Ferrante JM, Winston DG, Chen PH, de la Torre AD Family Physicians’ Knowledge and Practices Regarding Chronic Hepatitis and Monitoring for Liver Cancer. Family Medicine Family Medicine 2008 May: 40(5), 345-351
25. Koneru B, Shareef A, Dikdan G, Desai K, Klein KM, Peng B, Wachsberg RH, de la Torre AN, Debroy M, Fisher A, Wilson DJ, Samanta AK. The ischemic preconditioningparadox in deceased donor liver transplantation- evidence from a prospectiverandomized single blind clinical trial. Am J Transplant. 2007 Dec;7(12):2788-96.
24. Abujudeh H, Contractor D, delaTorre A, Koneru B. Rescue TIPS in acute Budd-Chiari syndrome. AJR Am J Roentgenol. 2005 Jul;185(1):89-91.
23. Ponnudurai RN, Koneru B, Akhtar SA, Wachsberg RH, Fisher A, Wilson DJ, de la Torre AN. Vasopressor administration during liver transplant surgery and its effect on endotracheal reintubation rate in the postoperative period: a prospective, randomized, double-blind, placebo-controlled trial. Clin Ther. 2005 Feb;27(2):192-8.
22. Koneru B, Fisher A, He Y, Klein KM, Skurnick J, Wilson DJ, de la Torre AN, Merchant A, Arora R, Samanta AK. Ischemic preconditioning in deceased donor liver transplantation: a prospective randomized clinical trial of safety and efficacy. Liver Transpl. 2005 Feb;11(2):196-202.
21. Harrison LE, Reichman T, Koneru B, Fisher A, Wilson D, dela Torre A, Samanta A, Korogodsky M. Racial discrepancies in the outcome of patients with hepatocellular carcinoma. Arch Surg. 2004 Sep;139(9):992-6.
20. de la Torre AN, Fisher A, Wilson DJ, Reitsma W, Goerlitz F, Koneru. Minimally Invasive Optimization of Organ Donor Resuscitation: Case Reports. Prog Transplant. 2005 Mar;15(1):27-32.
19. Fisher A, Seguel JM, de la Torre AN, Wilson D, Merchant A, Arora RK, Koneru B. Effect of sirolimus on infection incidence in liver transplant recipients. Liver Transpl. 2004 Feb;10(2):193-8.
18. Dikdan, GS, Saba SC, de la Torre AD, Roth JR, Wang S, Koneru B. Role of Oxidative Stress in the Increased Activation of Signal Transducers and Activators of Transcription-3 in the Fatty Livers of Obese Zucker Rats. Surgery 2004 136(3):677
17. de la Torre AN, Fisher A, Wilson DJ, Harrison J, Koneru B. A Case Report of Donor to Recipient Transmission of Severe Thrombocytopenia Purpura. Transplantation. 2004 May 15;77(9):1473-4
16. Harrison LE, Koneru B, Baramipour P, Fisher A, Barone A, Wilson D, dela Torre AN, Cho KC, Contractor D, Korogodsky M. Locoregional recurrences are frequent after radiofrequency ablation for Hepatocellular carcinoma. J Am Coll Surg J Am Coll Surg. 2003 Nov; 197(5): 759-64.
15. Monteiro I, McLoughlin LM, Fisher A, dela Torre AN, Koneru B. Rituximab with plasmapheresis and splenectomy in ABO-Incompatible liver transplantation. Transplantation 2003; 76(11):1648
14. Das K, Fisher A, Wilson DJ, dela Torre AN, Seguel J, Koneru B. Primary non-Hodgkin’s lymphoma of the bile ducts mimicking cholangiocarcinoma: Report of two cases and review of the literature. Surgery 2003 Sep; 134(3):496
13. Wilson DJ, Fisher A, Das K, Goerlitz F, Holland BK, de la Torre AN, Merchant A, Seguel J, Samanta AK, Koneru B.. Donors with cardiac arrest: Improved organ recovery but no preconditioning benefit in liver allografts. Transplantation 2003; 75:1683-1687.
12. Koneru B, Fisher A, Wilson DJ, Klein KM, de la Torre AN, Seguel J. De novo pulmonary hypertension following successful liver transplantation. Am J Transplant. 2002 Oct;2(9):883-6.
11. delaTorre A.N., Schroeder R.A., Punzulan C., Kuo P.C.: Endotoxin-mediated S-nitrosylation of p50 alters nf-kappa B-dependent gene transcription in ANA-1 murine macrophages. Journal of Immunology 1999; 162(7): 4101. 1999.
10. delaTorre A.N., Schroeder R.A., Bartlett S.T., Kuo P.C.: Differential Effects of Nitric Oxide-mediated S-nitrosylation on p50 and c-jun DNA Binding. Surgery. 1998; 124(2):137.
9. Kuo P.C., Drachenberg C.I., delaTorre A.N., Bartlett S.T., Lim J.W., Plotkin J.S., Johnson L.B.: Apoptosis and Hepatic Allograft Reperfusion Injury. Clinical Transplantation. 1997; 12(3):219.
8. delaTorre A.N., Schroeder R.A., Kuo P.C.: Alteration of NF-kappa B p50 Binding Kinetics by S-Nitrosylation. Biophysical Bioresearch Communications. 1997; 238(3):703.
7. Bartlett S.T., Schweitzer E.J., Kuo P.C., Johnson L.B., delaTorre A.N., Hadley G.A.: Prevention of Autoimmune Islet Allograft Destruction by Engraftment of Donor T Cells. Transplantation 1997; 63(2):299.
6. Schroeder R.A., delaTorre A.N., Kuo P.C.: A CD14 Dependent Mechanism For Endotoxin-Mediated Nitric Oxide Synthesis In Murine Macrophages. American Journal of Physiology 1997; 273(1):C1030.
5. Bartlett S.T., delaTorre A.N., Johnson L.B., Kuo P.C., Schweitzer E.J.: Long-Term Pancreatic Function: Potential Benefits. Transplantation Proceedings 1997; 28(4):2128.
4. Johnson L.B., Kuo P.C., Schweitzer E.J., Ratner L.E., Klassen D.K., Hoehn-Saric E.W., delaTorre A.N., Weir M.R., Strange J., Bartlett S.T: Double Renal Allografts Successfully Increase Utilization of Kidneys from Older Donors Within a Single Organ Procurement Organization. Transplantation 1997; 62(11):1581.
3. Kuo P.C., delaTorre A.N., Johnson, L.B., Schweitzer, E.J., Bartlett, S.T.: Bilateral Retroperitoneal Renal Allografts: Technique for Placement Through a Midline Incision. Journal of the American College of Surgeons 1997; 183(5):529.
2. delaTorre A.N., Kuo P.C., Plotkin J.S., Ridge L.A., Howell C.D., Bartlett S.T., Johnson L.B.: Influence of Donor Base Deficit Status on Recipient Outcomes in Liver Transplantation. Transplantation Proceeding 1997; 29(1-2):474.
1. Koneru B, Reddy M.C., delaTorre, A.N., Patel P, Ippolito T, Ferrante R.J.: Studies of Hepatic Warm Ischemia in the Obese Zucker Rat. Transplantation 1995; 59(7):942.
34. de la Torre AN, Contractor S, Castaneda I, Cathcart C, Razdan D, Clyde D, Kisza P, Gonzalez S, Salazar. A Phase I trial using local regional treatment, nonlethal irradiation, intratumoral and systemic polyinosinic-polycytidylic acid polylysine carboxymethylcellulose to treat liver cancer: in search of the abscopal effect. J Hepatocell Carcinoma. 2017 Aug 7;4:111-121
33. de la Torre AN, Castaneda I, Elkholy N, Tham N, Peyton A, Samanta A, Leevy CB.. Patient Targeted Informatics to Increase Blood Testing, Diagnosis and Vaccination in High Risk Populations for Chronic Viral Hepatitis. 2017 Jun 21. JVH [Epub ahead of print]
32. Lasfer A, Ziosa A, de la Torre AD, Cohen-Solal, KA IFN-λ: A New Inducer of Local Immunity against Cancer and Infections. Frontiers in Immunology 2016 December 15; 7: 598
31. Lasfar A, de la Torre AN, Abushahba W, Cohen-Solal KA, Castaneda I, Yuan Y, Reuhl K, Raveche E, Laskin DL, Kotenko SV. Combination of IFN-α and IFN-λ induce complete remission in BNL hepatoma model: Relevance of IFN-α/λ cross-talk and host immunomodulation. Oncotarget 2016 Aug 2; 7(31): 49259–49267
30 Botros Y, Mathews M, Patel H, Shah N, Baddoura W, de la Torre A Case Report Recurrent Hepatocellular Carcinoma in Patient with Crohn’s Disease: Incidental or Expected Outcome of Azathioprine? . Recurrent Hepatocellular Carcinoma in Patient with Crohn’s Disease: Incidental or Expected Outcome of Azathioprine?. Case Reports in Gastrointestinal Medicine 2015;2015:939136
29. Ambovex® as a novel immunological modulator drug for treatment of Hepato-Cellular Carcinoma (HCC) in liver: Phase II clinical trial. Salama H, Ahmad H, Elchagea I, Zekri RA, Medhat E, Bahnassy A, Lange M, Rabbat M, de la Torre AN, Punamiya P. Journal of Hepatocellular Carcinoma 2015 2:79-89
28. Muir AJ, Shiffman ML, Zaman A, Yoffe B, de la Torre A, Flamm S, Gordon S, Marotta P, Vierling J, Lopez-Talavera JC, Byrnes-Blake K, Fontana D, Freeman J, Gray T, Hausman D, Hunder NN, Lawitz E. Phase 1b Dose- Ranging Study of PEG-Interferon-Lambda Plus Ribavirin in Patients with Chronic Genotype 1 Hepatitis C Virus Infection. Hepatology. 2010 May 14
27. Abushahba W, Lasfar A , Balan M, Castaneda I, Yuan Y, Prescott L, Reuhl K, Raveche E, de la Torre AN, Kotenko SV. Antitumor Activity of Type I and Type III Interferons in BNL Hepatoma Model. Cancer Immunol Immunother. 2010 Mar 9
26. Ferrante JM, Winston DG, Chen PH, de la Torre AD Family Physicians’ Knowledge and Practices Regarding Chronic Hepatitis and Monitoring for Liver Cancer. Family Medicine Family Medicine 2008 May: 40(5), 345-351
25. Koneru B, Shareef A, Dikdan G, Desai K, Klein KM, Peng B, Wachsberg RH, de la Torre AN, Debroy M, Fisher A, Wilson DJ, Samanta AK. The ischemic preconditioningparadox in deceased donor liver transplantation- evidence from a prospectiverandomized single blind clinical trial. Am J Transplant. 2007 Dec;7(12):2788-96.
24. Abujudeh H, Contractor D, delaTorre A, Koneru B. Rescue TIPS in acute Budd-Chiari syndrome. AJR Am J Roentgenol. 2005 Jul;185(1):89-91.
23. Ponnudurai RN, Koneru B, Akhtar SA, Wachsberg RH, Fisher A, Wilson DJ, de la Torre AN. Vasopressor administration during liver transplant surgery and its effect on endotracheal reintubation rate in the postoperative period: a prospective, randomized, double-blind, placebo-controlled trial. Clin Ther. 2005 Feb;27(2):192-8.
22. Koneru B, Fisher A, He Y, Klein KM, Skurnick J, Wilson DJ, de la Torre AN, Merchant A, Arora R, Samanta AK. Ischemic preconditioning in deceased donor liver transplantation: a prospective randomized clinical trial of safety and efficacy. Liver Transpl. 2005 Feb;11(2):196-202.
21. Harrison LE, Reichman T, Koneru B, Fisher A, Wilson D, dela Torre A, Samanta A, Korogodsky M. Racial discrepancies in the outcome of patients with hepatocellular carcinoma. Arch Surg. 2004 Sep;139(9):992-6.
20. de la Torre AN, Fisher A, Wilson DJ, Reitsma W, Goerlitz F, Koneru. Minimally Invasive Optimization of Organ Donor Resuscitation: Case Reports. Prog Transplant. 2005 Mar;15(1):27-32.
19. Fisher A, Seguel JM, de la Torre AN, Wilson D, Merchant A, Arora RK, Koneru B. Effect of sirolimus on infection incidence in liver transplant recipients. Liver Transpl. 2004 Feb;10(2):193-8.
18. Dikdan, GS, Saba SC, de la Torre AD, Roth JR, Wang S, Koneru B. Role of Oxidative Stress in the Increased Activation of Signal Transducers and Activators of Transcription-3 in the Fatty Livers of Obese Zucker Rats. Surgery 2004 136(3):677
17. de la Torre AN, Fisher A, Wilson DJ, Harrison J, Koneru B. A Case Report of Donor to Recipient Transmission of Severe Thrombocytopenia Purpura. Transplantation. 2004 May 15;77(9):1473-4
16. Harrison LE, Koneru B, Baramipour P, Fisher A, Barone A, Wilson D, dela Torre AN, Cho KC, Contractor D, Korogodsky M. Locoregional recurrences are frequent after radiofrequency ablation for Hepatocellular carcinoma. J Am Coll Surg J Am Coll Surg. 2003 Nov; 197(5): 759-64.
15. Monteiro I, McLoughlin LM, Fisher A, dela Torre AN, Koneru B. Rituximab with plasmapheresis and splenectomy in ABO-Incompatible liver transplantation. Transplantation 2003; 76(11):1648
14. Das K, Fisher A, Wilson DJ, dela Torre AN, Seguel J, Koneru B. Primary non-Hodgkin’s lymphoma of the bile ducts mimicking cholangiocarcinoma: Report of two cases and review of the literature. Surgery 2003 Sep; 134(3):496
13. Wilson DJ, Fisher A, Das K, Goerlitz F, Holland BK, de la Torre AN, Merchant A, Seguel J, Samanta AK, Koneru B.. Donors with cardiac arrest: Improved organ recovery but no preconditioning benefit in liver allografts. Transplantation 2003; 75:1683-1687.
12. Koneru B, Fisher A, Wilson DJ, Klein KM, de la Torre AN, Seguel J. De novo pulmonary hypertension following successful liver transplantation. Am J Transplant. 2002 Oct;2(9):883-6.
11. delaTorre A.N., Schroeder R.A., Punzulan C., Kuo P.C.: Endotoxin-mediated S-nitrosylation of p50 alters nf-kappa B-dependent gene transcription in ANA-1 murine macrophages. Journal of Immunology 1999; 162(7): 4101. 1999.
10. delaTorre A.N., Schroeder R.A., Bartlett S.T., Kuo P.C.: Differential Effects of Nitric Oxide-mediated S-nitrosylation on p50 and c-jun DNA Binding. Surgery. 1998; 124(2):137.
9. Kuo P.C., Drachenberg C.I., delaTorre A.N., Bartlett S.T., Lim J.W., Plotkin J.S., Johnson L.B.: Apoptosis and Hepatic Allograft Reperfusion Injury. Clinical Transplantation. 1997; 12(3):219.
8. delaTorre A.N., Schroeder R.A., Kuo P.C.: Alteration of NF-kappa B p50 Binding Kinetics by S-Nitrosylation. Biophysical Bioresearch Communications. 1997; 238(3):703.
7. Bartlett S.T., Schweitzer E.J., Kuo P.C., Johnson L.B., delaTorre A.N., Hadley G.A.: Prevention of Autoimmune Islet Allograft Destruction by Engraftment of Donor T Cells. Transplantation 1997; 63(2):299.
6. Schroeder R.A., delaTorre A.N., Kuo P.C.: A CD14 Dependent Mechanism For Endotoxin-Mediated Nitric Oxide Synthesis In Murine Macrophages. American Journal of Physiology 1997; 273(1):C1030.
5. Bartlett S.T., delaTorre A.N., Johnson L.B., Kuo P.C., Schweitzer E.J.: Long-Term Pancreatic Function: Potential Benefits. Transplantation Proceedings 1997; 28(4):2128.
4. Johnson L.B., Kuo P.C., Schweitzer E.J., Ratner L.E., Klassen D.K., Hoehn-Saric E.W., delaTorre A.N., Weir M.R., Strange J., Bartlett S.T: Double Renal Allografts Successfully Increase Utilization of Kidneys from Older Donors Within a Single Organ Procurement Organization. Transplantation 1997; 62(11):1581.
3. Kuo P.C., delaTorre A.N., Johnson, L.B., Schweitzer, E.J., Bartlett, S.T.: Bilateral Retroperitoneal Renal Allografts: Technique for Placement Through a Midline Incision. Journal of the American College of Surgeons 1997; 183(5):529.
2. delaTorre A.N., Kuo P.C., Plotkin J.S., Ridge L.A., Howell C.D., Bartlett S.T., Johnson L.B.: Influence of Donor Base Deficit Status on Recipient Outcomes in Liver Transplantation. Transplantation Proceeding 1997; 29(1-2):474.
1. Koneru B, Reddy M.C., delaTorre, A.N., Patel P, Ippolito T, Ferrante R.J.: Studies of Hepatic Warm Ischemia in the Obese Zucker Rat. Transplantation 1995; 59(7):942.
Gilead
Director: 2016-2018
Automated EMR Based “Baby Boomer” HCV Blood Testing and Region of Birth HBV/HCV Blood Testing in an Urban Culturally Diverse Population Combined with Patient Navigation and Likage to Care
Healthcare Foundation of New Jersey
Principle Investigator: 2011-2012
Use of Audio-Computer Assisted Survey Interview to Increase Viral Hepatitis Screening
Healthcare Foundation of New Jersey
Principle Investigator 2007
A Clinical Approach to Understand the Underdiagnosis and Treatment of Hepatitis C and B
Roche Pharmaceutical
Principle Investigator 2007
Use of Audio-Computer Assisted Survey interview to Engage People in Need of Chronic Viral Hepatitis Blood Testing
Bayer Pharmaceutical
Principle Investigator 2009
Phase II Pilot Study of Sorafenib Tosylate Before and After Hepatic Arterial Chemoembolization With Doxorubicin Hydrochloride and Mitomycin C in Patients With Localized Unresectable Hepatocellular Carcinoma
Gilead Pharmaceutical
Principle Investigator 2009
A Clinical Approach to Understand Obstacles To the Diagnosis of Chronic Viral Hepatitis in Order to Improve Early Diagnosis of Liver Cancer
Human Services and Resources Administration 08-130:
Principle Investigator 2009
Patient Navigation to Increase Access to Chronic Viral Hepatitis Treatment and Liver Cancer Screening in Low Income Urban Communities Subject to Health Disparities
Healthcare Foundation of New Jersey
Principle Investigator: 2010
Support and Optimization of Infrastructure to Reduce Liver Disease Mortality
Director: 2016-2018
Automated EMR Based “Baby Boomer” HCV Blood Testing and Region of Birth HBV/HCV Blood Testing in an Urban Culturally Diverse Population Combined with Patient Navigation and Likage to Care
Healthcare Foundation of New Jersey
Principle Investigator: 2011-2012
Use of Audio-Computer Assisted Survey Interview to Increase Viral Hepatitis Screening
Healthcare Foundation of New Jersey
Principle Investigator 2007
A Clinical Approach to Understand the Underdiagnosis and Treatment of Hepatitis C and B
Roche Pharmaceutical
Principle Investigator 2007
Use of Audio-Computer Assisted Survey interview to Engage People in Need of Chronic Viral Hepatitis Blood Testing
Bayer Pharmaceutical
Principle Investigator 2009
Phase II Pilot Study of Sorafenib Tosylate Before and After Hepatic Arterial Chemoembolization With Doxorubicin Hydrochloride and Mitomycin C in Patients With Localized Unresectable Hepatocellular Carcinoma
Gilead Pharmaceutical
Principle Investigator 2009
A Clinical Approach to Understand Obstacles To the Diagnosis of Chronic Viral Hepatitis in Order to Improve Early Diagnosis of Liver Cancer
Human Services and Resources Administration 08-130:
Principle Investigator 2009
Patient Navigation to Increase Access to Chronic Viral Hepatitis Treatment and Liver Cancer Screening in Low Income Urban Communities Subject to Health Disparities
Healthcare Foundation of New Jersey
Principle Investigator: 2010
Support and Optimization of Infrastructure to Reduce Liver Disease Mortality
American Liver Foundation, Medical Advisory Board 2017-present
Medical Advisor Latino Organization for Liver Awareness 2004-2010
Vice Medical Director New Jersey Tissue and Organ Sharing Network 2005-2010
New Jersey State DOH Chronic Viral Hepatitis Advisory Board 2006-present
Board of Directors: New Jersey Tissue and Organ Sharing Network 2007-2010
Vice-Chairman: New Jersey Hep-Help Alliance: October 2008-present
Medical Advisor Latino Organization for Liver Awareness 2004-2010
Vice Medical Director New Jersey Tissue and Organ Sharing Network 2005-2010
New Jersey State DOH Chronic Viral Hepatitis Advisory Board 2006-present
Board of Directors: New Jersey Tissue and Organ Sharing Network 2007-2010
Vice-Chairman: New Jersey Hep-Help Alliance: October 2008-present
liver cancer treatment in new jersey, liver cancer surgery in new jersey, pancreas cancer surgery in new jersey, bile duct cancer surgery in new jersey, hepatobiliary surgery in new jersey, pancreatitis surgery in new jersey, portal hypertension care in new jersey, mesocaval shunt in new jersey, laparoscopic liver surgery, laparoscopic pancreas surgery, laparoscopic hepatobiliary surgery
liver cancer treatment in new jersey, liver cancer surgery in new jersey, pancreas cancer surgery in new jersey, bile duct cancer surgery in new jersey, hepatobiliary surgery in new jersey, pancreatitis surgery in new jersey, portal hypertension care in new jersey, mesocaval shunt in new jersey, laparoscopic liver surgery, laparoscopic pancreas surgery, laparoscopic hepatobiliary surgery
With over a decade of experience as a liver transplant specialist and surgeon, Dr de la Torre has almost 20 of experience caring for patients with complications from cirrhosis. In addition to performing complex surgery, he has run nuerous programs to improve early diagnosis of liver disease and liver cancer, as well as run multiple clinical trials. In 2016 Dr de la Torre received an award from the World Health Organization for his efforts. He is published in peer review journals on how to use hospital computer systems to identify patients with liver disease before the liver becomes damaged, thus avoiding liver cancer, or need for liver transplant.
liver cancer treatment in new jersey, liver cancer surgery in new jersey, pancreas cancer surgery in new jersey, bile duct cancer surgery in new jersey, hepatobiliary surgery in new jersey, pancreatitis surgery in new jersey, portal hypertension care in new jersey, mesocaval shunt in new jersey, laparoscopic liver surgery, laparoscopic pancreas surgery, laparoscopic hepatobiliary surgery
Dr Smith is Chief of Interventional Radiology at Bayonne Medical Center. He specializes in treating non-surgical cancers of the liver.
liver cancer treatment in new jersey, liver cancer surgery in new jersey, pancreas cancer surgery in new jersey, bile duct cancer surgery in new jersey, hepatobiliary surgery in new jersey, pancreatitis surgery in new jersey, portal hypertension care in new jersey, mesocaval shunt in new jersey, laparoscopic liver surgery, laparoscopic pancreas surgery, laparoscopic hepatobiliary surgery
liver cancer treatment in new jersey, liver cancer surgery in new jersey, pancreas cancer surgery in new jersey, bile duct cancer surgery in new jersey, hepatobiliary surgery in new jersey, pancreatitis surgery in new jersey, portal hypertension care in new jersey, mesocaval shunt in new jersey, laparoscopic liver surgery, laparoscopic pancreas surgery, laparoscopic hepatobiliary surgery, Jersey city, hudson county, bayonne, hoboken
